Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société GLAXOSMITHKLINE PLC
01/22GLAXOSMITHKLINE : ViiV Healthcare announces FDA approval of Cabenuva (cabotegrav..
AQ
01/22BIONDVAX PHARMACEUTICALS : Announces Appointment of Amir Reichman as New CEO
AQ
01/22GLAXOSMITHKLINE : GSK - ViiV Healthcare announces FDA approval of Cabenuva, the ..
AQ
01/19GLAXOSMITHKLINE : ViiV Healthcare and Chelsea and Westminster Hospital continue ..
AQ
01/19GLAXOSMITHKLINE : GSK and Novartis announce collaboration to support scientific ..
PU
01/18HIKMA PHARMACEUTICALS : provides update on generic Advair Diskus launch
AQ
01/14GLAXOSMITHKLINE : Conference transcript PDF - 125.9KB
PU
01/13GLAXOSMITHKLINE : ViiV Healthcare receives EU Marketing Authorisation for the fi..
PU
01/12GLAXOSMITHKLINE : JP Morgan Conference presentation
PU
01/08GLAXOSMITHKLINE : GSK, MMV filing for Kozenis (tafenoquine) in paediatric popula..
PU
2020GLAXOSMITHKLINE : Morgan Stanley ESG Conference presentation PDF - 366.3KB
PU
2020Vectura earns $11m milestone as Hikma receives US FDA approval for generic Ad..
AQ
2020HIKMA PHARMACEUTICALS : launches generic Advair Diskus following FDA approval
AQ
2020GLAXOSMITHKLINE : GSK and Ahren Announce Co-Led Series A Investment in Adrestia,..
PU
2020GLAXOSMITHKLINE : Vir Biotechnology and GSK announce start of NIH-sponsored ACTI..
PU
2020GLAXOSMITHKLINE : FDA approves GSK's BENLYSTA as the first medicine for adult pa..
PU
2020GLAXOSMITHKLINE : Sanofi and GSK announce a delay in their adjuvanted recombinan..
PU
2020GLAXOSMITHKLINE : FDA accepts GSK's filing of Nucala (mepolizumab) for use in ch..
PU
2020ViiV Healthcare and Shutterstock Studios unite to tackle outdated perceptions..
AQ
2020GLAXOSMITHKLINE : ViiV Healthcare and the Medicines Patent Pool expand access to..
AQ
2020GLAXOSMITHKLINE : GSK starts phase 3 study of RSV maternal candidate vaccine
AQ
2020GLAXOSMITHKLINE : GSK starts phase 3 study of RSV maternal candidate vaccine
PU
2020VECTURA : provides update on GSK litigation
AQ
2020GLAXOSMITHKLINE : GSK and MMV present positive data on treatment for Plasmodium ..
PU
2020GLAXOSMITHKLINE : ViiV Healthcare announces results of the PROgress study demons..
AQ
2020GLAXOSMITHKLINE : ViiV Healthcare receives FDA Breakthrough Therapy Designation ..
AQ
2020GLAXOSMITHKLINE : ViiV Healthcare receives FDA Breakthrough Therapy Designation ..
PU
2020GLAXOSMITHKLINE : ViiV Healthcare announces CHMP positive opinion for the first-..
AQ
2020GLAXOSMITHKLINE : GSK presents Phase 2b data on linerixibat for the treatment of..
PU
2020GLAXOSMITHKLINE : ViiV Healthcare announces CHMP positive opinion for the first-..
PU
2020GLAXOSMITHKLINE : Medicago and GSK announce start of Phase 2/3 clinical trials o..
PU
2020GLAXOSMITHKLINE : ViiV Healthcare announces investigational injectable cabotegra..
AQ
2020GLAXOSMITHKLINE : Horizon Therapeutics plc Names Karin Rosen, M.D., Ph.D. Execut..
AQ
2020GLAXOSMITHKLINE : GSK sets new environmental goals of net zero impact on climate..
PU
2020GLAXOSMITHKLINE : European Commission approves Zejula (niraparib) as first-line ..
PU
2020GLAXOSMITHKLINE : GSK Nucala (mepolizumab) filings accepted by European Medicine..
PU
2020GLAXOSMITHKLINE : Q3 2020 results transcript
PU
2020GLAXOSMITHKLINE : Q3 2020 US Dollar Translation PDF - 155.1KB
PU
2020GLAXOSMITHKLINE : Q3 2020 results slides PDF - 723.5KB
PU
2020GLAXOSMITHKLINE : Q3 2020 Results Announcement PDF - 966.6KB
PU
2020GLAXOSMITHKLINE : Q3 2020 Results Infographic PDF - 441.9KB
PU
2020GLAXOSMITHKLINE : GSK delivers resilient performance, strong commercial executio..
PU
2020GLAXOSMITHKLINE : Sanofi and GSK to support COVAX with 200 million doses of adju..
PU
2020ANAPTYSBIO : and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration
AQ
2020GLAXOSMITHKLINE : GSK - ViiV Healthcare presents continued positive findings fro..
AQ
2020Noveome Biotherapeutics, Inc. Announces New Appointments to its Board of Dire..
AQ
2020GLAXOSMITHKLINE : ViiV Healthcare presents positive new findings from two studie..
PU
2020GLAXOSMITHKLINE : ViiV Healthcare presents continued positive findings from firs..
PU
2020GLAXOSMITHKLINE : ViiV Healthcare announces analysis showing no antiretroviral t..
PU
2020GLAXOSMITHKLINE : GSK presents positive clinical data on maternal and older adul..
PU
2020ViiV Healthcare receives positive CHMP opinion for long-acting regimen for th..
AQ
2020GLAXOSMITHKLINE : ViiV Healthcare receives positive CHMP opinion for long-acting..
PU
2020Enzymatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukrai..
AQ
2020GLAXOSMITHKLINE : Q3 2020 pre announcement aide memoire
PU
2020GLAXOSMITHKLINE : ViiV Healthcare presents long-term switch data for Dovato demo..
PU
2020GKN Aerospace leading smart manufacturing project to increase productivity
AQ
2020VIR BIOTECHNOLOGY : and GSK announce global expansion to Phase 3 of COMET-ICE st..
AQ
2020GLAXOSMITHKLINE : ViiV Healthcare announces dolutegravir plus lamivudine three-y..
PU
2020GLAXOSMITHKLINE : ViiV Healthcare announces dolutegravir plus lamivudine three-y..
PU
2020GLAXOSMITHKLINE : ViiV Healthcare to present long-term safety and efficacy data ..
PU
2020GLAXOSMITHKLINE : FDA approves Nucala as the first and only biologic treatment f..
AQ
2020GLAXOSMITHKLINE : Clover Announces Positive Preclinical Data and Updates on Phas..
AQ
2020GLAXOSMITHKLINE : ViiV Healthcare announces start of implementation science stud..
PU
2020GLAXOSMITHKLINE : FDA Approves Nucala as the First and Only Biologic Treatment f..
BU
2020GLAXOSMITHKLINE : FDA approves Nucala as the first and only biologic treatment f..
PU
2020PFIZER : ViiV Healthcare Announces Availability of CABENUVA and VOCABRIA in Cana..
AQ
2020GLAXOSMITHKLINE : Sanofi and GSK sign agreements with the Government of Canada t..
PU
2020GLAXOSMITHKLINE : GSK receives CHMP positive opinion recommending approval of Ze..
PU
2020GLAXOSMITHKLINE : Sanofi and GSK confirm agreement with European Union to supply..
PU
2020GLAXOSMITHKLINE : FDA approves Trelegy Ellipta as the first once-daily single in..
AQ
2020GLAXOSMITHKLINE : FDA Approves Trelegy Ellipta as the First Once-Daily Single In..
BU
2020GLAXOSMITHKLINE : FDA approves Trelegy Ellipta as the first once-daily single in..
PU
2020AstraZeneca - Biopharma Leaders Unite to Stand With Science
AQ
2020Biopharma Leaders Unite To Stand With Science
AQ
2020Biopharma Leaders Unite To Stand With Science; Nine CEOs sign historic pledge..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on GLAXOSMITHKLINE PLC